|
YPEL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.700200E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.703190E-03 |
| Normal-vs-Stage2 |
1.664840E-01 |
| Normal-vs-Stage3 |
6.951600E-01 |
| Normal-vs-Stage4 |
7.318800E-01 |
| Stage1-vs-Stage2 |
5.082600E-01 |
| Stage1-vs-Stage3 |
7.881300E-03 |
| Stage1-vs-Stage4 |
2.140300E-02 |
| Stage2-vs-Stage3 |
2.237600E-01 |
| Stage2-vs-Stage4 |
2.627600E-01 |
| Stage3-vs-Stage4 |
9.913000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.794200E-02 |
| Normal-vs-AfricanAmerican |
1.118050E-01 |
| Normal-vs-Asian |
2.454200E-02 |
| Caucasian-vs-AfricanAmerican |
6.850200E-01 |
| Caucasian-vs-Asian |
2.215400E-01 |
| AfricanAmerican-vs-Asian |
3.359600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.541900E-02 |
| Normal-vs-Female |
9.162000E-02 |
| Male-vs-Female |
5.638000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.958400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.755500E-03 |
| Normal-vs-Age(61-80Yrs) |
1.444610E-01 |
| Normal-vs-Age(81-100Yrs) |
8.578400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.142800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.450400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.532800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.153990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.367420E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.552000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.441060E-03 |
| Normal-vs-Grade 2 |
1.080670E-03 |
| Normal-vs-Grade 3 |
6.950100E-02 |
| Normal-vs-Grade 4 |
5.843800E-03 |
| Grade 1-vs-Grade 2 |
3.801500E-03 |
| Grade 1-vs-Grade 3 |
2.013500E-04 |
| Grade 1-vs-Grade 4 |
2.033400E-04 |
| Grade 2-vs-Grade 3 |
8.480100E-02 |
| Grade 2-vs-Grade 4 |
3.32520011525617E-10 |
| Grade 3-vs-Grade 4 |
6.44340000022225E-07 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.61400000000733E-05 |
| Normal-vs-ccB subtype |
5.535800E-01 |
| ccA subtype-vs-ccB subtype |
1.43039999955796E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.476430E-01 |
| Normal-vs-N1 |
2.062600E-01 |
| N0-vs-N1 |
3.206300E-02 |
|
|
